Watchlist Price Alert

Sino Biopharmaceutical Li... (SBHMY)

PNK: SBHMY · Real-Time Price · USD

9.75

-0.55 (-5.34%)

At close: May 07, 2025, 3:16 PM

Sino Biopharmaceutical Cash Flow Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	6.99B	5.93B	5.78B	18.57B	5.01B	5.58B	11.43B	4.2B	3.35B
Depreciation & Amortization	n/a	1.07B	1.05B	992.56M	1.65B	1.47B	1.18B	343.39M	353.09M
Stock-Based Compensation	53.72M	18.12M	29.72M	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	250.19M	195.51M	-281.66M	482.78M	170.79M	345.46M	454.37M	317.52M
Other Non-Cash Items	-1.85B	-529.74M	-394.56M	-13.86B	-1.6B	-1.45B	-7.75B	-1.24B	-887.6M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-430.51M	-195.59M	-339.13M	261.33M	-278.65M	243.3M	430.68M	273.59M
Operating Cash Flow	n/a	6.07B	6.27B	5.37B	5.33B	5.32B	5.09B	3.73B	3.09B
Capital Expenditures	n/a	-1.7B	-1.71B	-1.89B	-1.86B	-1.73B	-1.69B	-1.46B	-935.23M
Cash Acquisitions	n/a	-742.71M	-58.52M	-958.7M	-4.2B	-221.67M	1.2B	-288.4M	-28.31M
Purchase of Investments	n/a	-1.65B	-4.48B	-4.85B	-7.16B	-2.89B	-2.45B	-1.41B	-1.37B
Sales Maturities Of Investments	n/a	2.56B	1.08B	903.24M	5.12B	914.27M	2.17B	419.08M	142.02M
Other Investing Acitivies	n/a	142.09M	1.1B	4.28B	250.41M	111.82M	160.03M	759.52M	134.98M
Investing Cash Flow	n/a	-756.98M	-4.07B	-2.52B	-7.85B	-3.82B	-616.1M	-1.98B	-2.05B
Debt Repayment	n/a	-1.75B	1.05B	-1.64B	5.39B	5.2B	304.67M	-97.24M	1.6B
Common Stock Repurchased	n/a	-396.39M	-867.61M	-332.93M	-195.37M	-32.05M	-604.42M	n/a	n/a
Dividend Paid	n/a	-632.67M	-1.27B	-938.49M	-1.19B	-819.69M	-710.33M	-449.96M	-398.21M
Other Financial Acitivies	n/a	-3.77B	-2.1B	-316.24M	-1.77B	-1.55B	-1.17B	-1.15B	-658.91M
Financial Cash Flow	n/a	-6.55B	-3.19B	-3.23B	2.23B	2.8B	-2.18B	-1.35B	413.63M
Net Cash Flow	-1.27B	-1.15B	-944.73M	-1.02B	-7.02M	4.4B	2.54B	189.61M	1.23B
Free Cash Flow	n/a	4.36B	4.56B	3.47B	3.47B	3.59B	3.4B	2.27B	2.16B